摘要:
A chain and sprocket system includes a plurality of chains and sprockets. The system includes a crankshaft, an idler shaft and two overhead camshafts. The two sprockets on the idler shaft that connect by chain to drive the camshafts are phased or offset with respect to each other to alter the impact and chordal action generated noise. These idler camshaft sprockets and the idler sprocket of the crankshaft are all manufactured separately and then placed together on a spline or hub. In this way, the idler sprocket assembly consists of four parts, which eases manufacture and assembly.
摘要:
A chain and sprocket system includes a plurality of chains and sprockets. The system includes a crankshaft, an idler shaft and two overhead camshafts. The two sprockets on the idler shaft that connect by chain to drive the camshafts are phased or offset with respect to each other to alter the impact and chordal action generated noise. These idler camshaft sprockets and the idler sprocket of the crankshaft are all manufactured separately and then placed together on a spline or hub. In this way, the idler sprocket assembly consists of four parts, which eases manufacture and assembly.
摘要:
The invention provides compounds of formula (I): ##STR1## or a physiologically acceptable salt, solvate or metabolically labile ester thereof.The compounds may be used in the treatment or prophylaxis of hypertension and diseases associated with cognitive disorders.
摘要:
A fiber management device includes a support member including a first connector for releasably securing a first sidewall portion of an optical fiber bundle to the support member at a first fixed location and a drawer mounted for sliding movement relative to the support member, the drawer including a mounting surface, a plurality of fiber guiding components mounted on the mounting surface, and a second connector for releasably securing a second sidewall portion of the optical fiber bundle to the drawer at a second fixed location.
摘要:
The invention provides compounds of formula (I): ##STR1## or a physiologically acceptable salt, solvate or metabolically labile ester thereof wherein the R groups are defined in the specification.The compounds may be used in the treatment or prophylaxis of hypertension and diseases associated with cognitive disorders.